版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領(lǐng)
文檔簡介
右美托咪定對老年腰椎手術(shù)患者圍術(shù)期血流動力學與認知功能的影響摘要
目的:探討右美托咪定對老年腰椎手術(shù)患者圍術(shù)期血流動力學和認知功能的影響。
方法:選取60例老年腰椎手術(shù)患者,采用隨機數(shù)字表法分為對照組和觀察組各30例。對照組給予靜脈麻醉,觀察組給予右美托咪定。術(shù)前和術(shù)后第3天測定兩組患者的血流動力學參數(shù)和活性氧代謝水平,并測試兩組患者的認知功能。
結(jié)果:術(shù)后第3天,觀察組血流指數(shù)和血容量相比對照組增加(P<0.05),觀察組血鈣離子濃度低于對照組(P<0.05),而丙二醛、抗氧化酶等活性氧代謝水平均高于對照組(P<0.05)。同時,觀察組患者的認知功能明顯優(yōu)于對照組(P<0.05)。
結(jié)論:右美托咪定能夠提高老年腰椎手術(shù)患者術(shù)后血流動力學和抗氧化能力,且對術(shù)后認知功能有保護作用,可作為臨床上腰椎手術(shù)的麻醉藥物選擇之一。
關(guān)鍵詞:右美托咪定;老年人;腰椎手術(shù);血流動力學;認知功能
Abstract
Objective:Toinvestigatetheeffectofdexmedetomidineonperioperativehemodynamicsandcognitivefunctioninelderlypatientswithlumbarspinesurgery.
Methods:Sixtyelderlypatientswithlumbarspinesurgerywererandomlydividedintoacontrolgroupandanobservationgroupwith30casesineachgroup.Thecontrolgroupwasgivenintravenousanesthesia,andtheobservationgroupwasgivendexmedetomidine.Thehemodynamicparametersandreactiveoxygenmetabolismlevelsofthetwogroupsofpatientsweremeasuredbeforeandonthethirddayaftersurgery,andthecognitivefunctionofthetwogroupsofpatientswastested.
Results:Onthethirddayaftersurgery,thebloodflowindexandbloodvolumeoftheobservationgroupincreasedcomparedwiththecontrolgroup(P<0.05),andthebloodcalciumionconcentrationoftheobservationgroupwaslowerthanthatofthecontrolgroup(P<0.05).Thelevelsofactiveoxygenmetabolismsuchasmalondialdehydeandantioxidantenzymesintheobservationgroupwereallhigherthanthoseinthecontrolgroup(P<0.05).Meanwhile,thecognitivefunctionoftheobservationgroupwassignificantlybetterthanthatofthecontrolgroup(P<0.05).
Conclusion:Dexmedetomidinecanimprovepostoperativehemodynamicsandantioxidantcapacityofelderlypatientswithlumbarspinesurgery,andhasaprotectiveeffectonpostoperativecognitivefunction,whichcanbeusedasaclinicalanesthesiadrugforlumbarspinesurgery.
Keywords:Dexmedetomidine;Elderly;Lumbarspinesurgery;hemodynamics;cognitivefunctioLumbarspinesurgeryisacommonsurgicalprocedureforelderlypatients,andtheanesthesiamanagementandpostoperativecarearecrucialforthepatients'outcomes.Dexmedetomidineisaselectivealpha-2adrenergicreceptoragonistwithsedative,analgesic,andanxiolyticeffects,andhasbeenincreasinglyusedforperioperativesedationandanalgesia.Inthisstudy,weaimedtoinvestigatetheeffectsofdexmedetomidineonhemodynamics,antioxidantcapacity,andcognitivefunctioninelderlypatientsundergoinglumbarspinesurgery.
Ourresultsshowedthattheuseofdexmedetomidinesignificantlyimprovedthehemodynamicparameters,includingheartrateandmeanarterialpressure,duringtheperioperativeperiod.Thisfindingisconsistentwithpreviousstudiesthathaveshownthatdexmedetomidinecanreducesympatheticactivityandprovidestablehemodynamicconditionsduringsurgery.Theantioxidantcapacityoftheobservationgroupwasalsosignificantlyhigherthanthatofthecontrolgroup,suggestingthatdexmedetomidinemayhaveaprotectiveeffectagainstoxidativestressinducedbysurgeryandanesthesia.
Moreover,wefoundthatdexmedetomidinehadapositiveimpactonpostoperativecognitivefunctioninelderlypatients.Theobservationgrouphadbettercognitivefunctionthanthecontrolgroup,asassessedbytheMini-MentalStateExamination(MMSE)andMontrealCognitiveAssessment(MoCA)scores.Thisresultisconsistentwithpreviousstudiesthathavesuggestedthatdexmedetomidinecanreducetheriskofpostoperativedeliriumandcognitivedysfunctioninelderlypatients.
Inconclusion,ourstudysuggeststhatdexmedetomidinecanimprovepostoperativehemodynamicsandantioxidantcapacity,andhasaprotectiveeffectonpostoperativecognitivefunctioninelderlypatientsundergoinglumbarspinesurgery.Therefore,dexmedetomidinecanbeconsideredasapotentialanesthesiadrugforthispopulation.However,largerandmorerandomizedcontrolledtrialsareneededtoconfirmourfindingsandexploretheoptimaldoseanddurationofdexmedetomidineforthisindicationInadditiontothepotentialbenefitsofdexmedetomidineinelderlypatientsundergoinglumbarspinesurgery,therearestillsomelimitationsandchallengesthatneedtobeaddressedinfutureresearch.
Firstly,theoptimaldoseanddurationofdexmedetomidineforthisindicationremainunclear.Thedosageofdexmedetomidineusedinthestudiesincludedinthisreviewvariedfrom0.2μg/kg/hrto0.7μg/kg/hr,andthedurationofinfusionrangedfrom30minutesto24hours.Largerandmoreadequatelypoweredstudiesareneededtodeterminethemosteffectivedosageanddurationofdexmedetomidineinfusionforthispatientpopulation.
Secondly,thepotentialadverseeffectsofdexmedetomidine,suchashypotension,bradycardia,andsedation,shouldbecarefullymonitoredandmanaged.Althoughdexmedetomidineisgenerallyconsideredtobeasafeandwell-toleratedmedication,itcancauseasignificantdecreaseinbloodpressureandheartrate.Therefore,closehemodynamicmonitoringandappropriateinterventions,suchasfluidadministrationorvasopressorsupport,shouldbeimplementedasneeded.
Thirdly,thegeneralizabilityofthefindingstoothersurgicalpopulationsandsettingsshouldbecarefullyconsidered.Thestudiesreviewedinthisarticleprimarilyfocusedonelderlypatientsundergoinglumbarspinesurgery.Furtherinvestigationisneededtodeterminewhetherthepotentialbenefitsofdexmedetomidinecanbeextendedtoothersurgicalpopulations,suchasthoseundergoingcardiacormajorabdominalsurgery,andwhetherthefindingsareapplicableindifferenthealthcaresettings.
Finally,thecost-effectivenessofdexmedetomidineuseinelderlypatientsundergoinglumbarspinesurgeryshouldbeevaluated.Dexmedetomidineismoreexpensivethanothersedativeagents,anditsroutineuseinthispatientpopulationmayhavesignificantfinancialimplications.Furtherresearchisneededtodeterminewhetherthepotentialbenefitsofdexmedetomidineoutweighitscostsinthisindication.
Inconclusion,dexmedetomidineisapromisinganesthesiadrugforelderlypatientsundergoinglumbarspinesurgery.Ithasbeenshowntoimprovepostoperativehemodynamicsandantioxidantcapacity,andtohaveaprotectiveeffectonpostoperativecognitivefunction.However,furtherresearchisneededtodeterminetheoptimaldoseanddurationofinfusion,tocarefullymonitorandmanagepotentialadverseeffects,toevaluategeneralizabilityoffindings,andtoassesscost-effectivenessofdexmedetomidineuseinthispatientpopulationInadditiontothepotentialbenefitsofdexmedetomidineinelderlypatientsundergoinglumbarspinesurgery,therearealsopotentialrisksandlimitationsofitsuse.Dexmedetomidineisarelativelynewdrug,anditssafetyandefficacyinspecificpatientpopulations,suchasolderadults,havenotbeenfullyestablished.Additionally,dexmedetomidinecancausehypotension,bradycardia,andrespiratorydepression,whichcanbeparticularlydangerousinelderlypatientswhomayhavepreexistingcardiovascularorrespiratoryconditions.
Furthermore,dexmedetomidineismoreexpensivethanothersedativescommonlyusedinanesthesia,suchaspropofolormidazolam,whichmaylimititsuseinsomehealthcaresettings.Finally,theoptimaldoseanddurationofdexmedetomidineinfusioninelderlypatientsundergoinglumbarspinesurgeryisnotyetclear,whichcouldpotentiallyleadtoover-orunder-treatmentandpooroutcomes.
Toaddresstheselimitationsanduncertainties,furtherresearchisneededtodeterminethesafetyandefficacyofdexmedetomidineinelderlypatientsundergoinglumbarspinesurgery.Thisresearchshouldincluderandomizedcontrolledtrialscomparingdexmedetomidinetoothersedativesandassessingbothshort-andlong-termoutcomes,suchaspostoperativemortality,morbidity,andqualityoflife.
Inaddition,studiesshouldbedesignedtocarefullymonitorandmanagepotentialadverseeffectsofdexmedetomidine,suchashypotensionandbradycardia,andtoevaluatethecost-effectivenessofdexmedetomidineuseinthispatientpopulation.Finally,futureresearchshouldassessthegeneralizabilityoffindingstootherpatientpopulations,suchasthosewithdifferenttypesofsurgeryorcomorbidconditions.
Inconclusion,dexmedetomidineshowspromiseasasedativef
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
- 6. 下載文件中如有侵權(quán)或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 保險經(jīng)紀人操作技能水平考核試卷含答案
- 房地產(chǎn)策劃師安全技能測試評優(yōu)考核試卷含答案
- 工業(yè)設計工藝師成果能力考核試卷含答案
- 互聯(lián)網(wǎng)服務場所管理員安全應急水平考核試卷含答案
- 光伏組件制造工崗前安全宣教考核試卷含答案
- 網(wǎng)站性能優(yōu)化技術(shù)方法詳解
- 八下數(shù)學第一講:平行四邊形性質(zhì)探索-從概念到應用的結(jié)構(gòu)化學習
- 《2026年》國企綜合管理崗位高頻面試題包含詳細解答
- 2026年及未來5年市場數(shù)據(jù)中國土壤咸化治理行業(yè)市場發(fā)展現(xiàn)狀及投資方向研究報告
- 2026年及未來5年市場數(shù)據(jù)中國家庭網(wǎng)關(guān)行業(yè)發(fā)展監(jiān)測及投資策略研究報告
- 癌癥患者生活質(zhì)量量表EORTC-QLQ-C30
- QCT55-2023汽車座椅舒適性試驗方法
- 孕產(chǎn)婦妊娠風險評估表
- 消化系統(tǒng)疾病健康教育宣教
- 河南省洛陽市2023-2024學年九年級第一學期期末質(zhì)量檢測數(shù)學試卷(人教版 含答案)
- Unit-3-Reading-and-thinking課文詳解課件-高中英語人教版必修第二冊
- 新版出口報關(guān)單模板
- 14K118 空調(diào)通風管道的加固
- 加油站財務管理制度細則
- 全過程工程咨詢服務技術(shù)方案
- YS/T 1152-2016粗氫氧化鈷
評論
0/150
提交評論